tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
CSPC Pharmaceutical Group Limited (CHJTF)
OTHER OTC:CHJTF
US Market
CHJTF
CSPC Pharmaceutical Group
RESEARCH TOOLSreports

CSPC Pharmaceutical Group (CHJTF) Stock News & Sentiment

Compare
28 Followers
CSPC Pharmaceutical Gains Approval for New Cancer Treatment Indication
Premium
Company Announcements
CSPC Pharmaceutical Gains Approval for New Cancer Treatment Indication
1d ago
CSPC Innovation Seeks H Share Listing Amid Expansion Plans
Premium
Company Announcements
CSPC Innovation Seeks H Share Listing Amid Expansion Plans
3d ago
CSPC Pharmaceutical Gains U.S. FDA Approval for JMT206 Clinical Trials
Premium
Company Announcements
CSPC Pharmaceutical Gains U.S. FDA Approval for JMT206 Clinical Trials
3d ago
CSPC Pharmaceutical’s Semaglutide Injection Gains NMPA Acceptance
Premium
Company Announcements
CSPC Pharmaceutical’s Semaglutide Injection Gains NMPA Acceptance
5d ago
CSPC’s Innovative Obesity Drug Receives U.S. Clinical Trial Approval
Premium
Company Announcements
CSPC’s Innovative Obesity Drug Receives U.S. Clinical Trial Approval
8d ago
CSPC Pharmaceutical’s Antidepressant Drug Gains U.S. FDA Trial Approval
Premium
Company Announcements
CSPC Pharmaceutical’s Antidepressant Drug Gains U.S. FDA Trial Approval
10d ago
CSPC Pharmaceutical’s JMT206 Receives Clinical Trial Approval in China
Premium
Company Announcements
CSPC Pharmaceutical’s JMT206 Receives Clinical Trial Approval in China
17d ago
More CHJTF News >

CHJTF News on the Web

CSPC Pharmaceutical Gains Approval for New Cancer Treatment Indication
TipRanks News
Neutral
CSPC Pharmaceutical Gains U.S. FDA Approval for JMT206 Clinical Trials
TipRanks News
Neutral
CSPC Pharmaceutical’s Antidepressant Drug Gains U.S. FDA Trial Approval
TipRanks News
Neutral
CSPC Pharmaceutical’s siRNA Drug Gains U.S. Clinical Trial Approval
TipRanks News
Neutral
CICC Keeps Their Buy Rating on CSPC Pharmaceutical Group (CHJTF)
TipRanks News
Neutral
Huatai Securities Remains a Buy on CSPC Pharmaceutical Group (CHJTF)
TipRanks News
Neutral
CSPC Pharmaceutical Group (CHJTF) Receives a Sell from Daiwa
TipRanks News
Neutral
CSPC Pharmaceutical Group Schedules Board Meeting for Q3 Results
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
CHJTF
Sector Average
Media Buzz
This Week2 articles
Weekly Average1.75 articles
News Sentiment
This Week50%
Sector Average57%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is CHJTF’s Media Buzz Sentiment?
2 articles about CHJTF were published this week. In an average week, 1.75 articles are published.
    What is CHJTF’s weekly average amount of articles?
    In an average week, 1.75 articles about CHJTF are published.
      What is CHJTF’s News Sentiment?
      50% of articles about CHJTF were positive this week, compared to its sector average of 57%.
        Healthcare Stocks that are Trending in the News
        XCURExicure
        SCLPScancell Holdings
        WVEWave Life Sciences
        STAAStaar Surgical
        KYMRKymera Therapeutics
        Showing the stocks with the most bullish news sentiment over the past week